Advanced Clinical Decision Support Platforms Market By Type (Therapeutic, Diagnostic), By Model (Knowledge based, Non Knowledge based), By Setting (Hospitals, Ambulatory care): Global Opportunity Analysis and Industry Forecast, 2021-2031

Advanced Clinical Decision Support Platforms Market

Advanced clinical decision support platforms are computerized systems that are designed to help healthcare professionals make better decisions about patient care. These platforms provide access to evidence-based medical knowledge and interactive tools to help in the assessment of a patient’s medical condition. The systems may also include decision support tools that help healthcare professionals make more informed decisions about care, such as drug dosing guidelines, drug-drug interaction warnings, and disease management protocols. These systems can be used to aid in diagnosis, treatment, and follow-up care.

Key factors driving the growth of the advanced clinical decision support platforms market include  increase in incidence of medical error, rise in the application of electronic health record, and advancement in R & D activities in medical sector. Increase in incidence of medical error is anticipated to drive the demand for advanced clinical decision support platform by professionals to get accurate information for diagnostic and therapeutic purposes. Thus, rising incidents of medical error is anticipated to boost the market growth. Medical errors are any preventable events that may cause or lead to inappropriate medical care or harm to a patient. Examples of medical errors include wrong diagnoses, improper or delayed treatment, or preventable adverse events. Clinical decision support systems (CDSS) are computer-based systems that help clinicians make decisions about patient care. CDSS can help to reduce medical errors by providing healthcare professionals with relevant and timely evidence-based information. Moreover, rise in the adoption of electronic health record system is anticipated to drive the growth of market. As advanced clinical decision support platform is a component of an electronic health record (EHR) system, thus, rise in application of EHR system in hospitals boosts the growth of market. In an EHR system, CDSS provides evidence-based recommendations and alerts to clinicians to help them make informed decisions about patient care. CDSS can help to reduce the risk of medical errors by providing timely, evidence-based information to clinicians. In addition, CDSS can help clinicians identify potential diagnosis or treatment options for a patient based on the patient's medical history and current symptoms.

The market also offers growth opportunities to the key players in the market.  Increase in number of key players to manufacture advanced clinical decision support platforms systems provide lucrative opportunities for growth and expansion of the market. For instance, VisualDx, a clinical decision support system (CDSS) software company, provides award-winning diagnostic clinical decision support system named as VisualDx, which is designed to enhance diagnostic accuracy, aid therapeutic decisions, and improve patient safety.  Moreover, in February 2023, Elsevier, a global leader in evidence-based clinical practice content, research publishing and information analytics, announced that their evidence-based oncology pathways solution, ClinicalPath, has been approved by the Centers for Medicare & Medicaid Services (CMS) as a clinical guideline for oncology practices participating in the new Enhanced Oncology Model (EOM).

The Advanced clinical decision support platforms Market is segmented into Type, Model, Setting, and Region. On the basis of Type, the market is categorized into therapeutic and diagnostic. The diagnostic segment is further bifurcated into hospitals and ambulatory care. Therapeutic segment is further subdivided into hospitals and ambulatory care. On the basis of model, the market is divided into knowledge based and non-knowledge based. By setting the market is categorized into hospital and ambulatory care. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players profiled in the study include Siemens Healthineers, Wolters Kluwer, Zynx Health, Oracle Corporation, IBM Watson Health, NextGen Healthcare Inc., Veradigm Inc., Meditech, Epic Systems Corporation, and Elsevier B.V.. The players in the market have been actively engaged in the adoption various strategies such as acquisition, and product launch to remain competitive and gain advantage over the competitors in the market. For instance, in October 2022, Epic, a developer of healthcare software, is getting ready to pilot Best Care. It possess the advantage of Cosmos to offer clinical decision support at the point of care by the use of real-world data.

Key Market Insights (Updated)

By type, the therapeutic segment was the highest revenue contributor and is estimated to be the fastest-growing segment with a CAGR of 9.4% during the forecast period.

By model, the knowledge based segment was the highest revenue contributor and is estimated to be the fastest-growing segment with a CAGR of 9.1% during the forecast period.

Based on setting, the hospitals segment was the highest revenue contributor to the market with a CAGR of 9.1% during the forecast period.

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 10.2% during the forecast period

Overview

The Advanced Clinical Decision Support Platforms Market valued for $496.4 million in 2021 and is estimated to reach $1,175.0 million by 2031, exhibiting a CAGR of 9.0% from 2022 to 2031. Advanced clinical decision support platforms or computerized clinical decision support systems (CDSS) represent a paradigm shift in healthcare sector. CDSS are used to augment clinicians in their complex decision-making processes. It is a type of system that offers health information technology to doctors, staff, patients, and other individuals with knowledge and person-specific information that are intelligently filtered or provided at the right moment to enhance health and health care. Clinical decision support systems are core component of electronic health records. These tools can alert the physician about potential errors, remind them to provide preventive care, help them to make diagnosis, and assist with treatment.

The growth of advanced clinical decision support platforms market is driven by technological advancement in the development of different clinical decision support systems and increase in number of various strategies adopted such as product launch and product approval by the key market players. In addition, rise in government initiatives for promoting digital healthcare boosts the market growth. Governments across the world are increasingly taking steps to promote digital health and the use of advanced clinical decision support systems. Thus, this factor is attributed to drive the demand for advanced clinical decision support systems and fuel the growth of market.

Moreover, there is rise in the prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases, which drives the demand for advanced clinical decision support systems, as these systems help healthcare professionals to provide better care for such conditions. Clinical decision support systems (CDSSs) can help clinicians to assess cardiovascular disease (CVD) risk & manage CVD risk factors by providing tailored assessments and treatment recommendations based on individual patient data. As Cardiovascular disease is the term for all types of diseases that affect the heart or blood vessels, including coronary heart disease, which can cause heart attacks, stroke, congenital heart defects, therefore, clinical decision support system can also be useful in treatment of coronary heart disease.

Thus, rise in prevalence of coronary heart disease fosters the demand for advanced clinical decision support system by physicians and fuels the growth of market. For instance, according to report shared by Center for Disease Control and Prevention (CDC), it was reported that, coronary heart disease is the most common type of heart disease, killing 382,820 people in the U.S. in 2020. Moreover, in 2020, about 2 in 10 deaths from coronary artery disease (CAD) were in adults less than 65 years old.

Clinical decision support systems are often integrated into telemedicine clinical practice. Thus, rise in usage of telemedicine platform by physician contributes to the growth of market. For instance, according to Centers for Disease Control and Prevention (CDC) in December 2022, it was reported that, from 2019 to 2021, the use of telemedicine technology increased for office-based physicians from 15.4% to 85.9%. In both 2019 and 2021, the use of telemedicine technology was higher among primary care physicians and medical specialty physicians On the other hand, high cost of electronic health record systems and cyber security issues associated with advanced clinical decision support platforms are some factors that are anticipated to restrain the growth of the advanced clinical decision support platforms market.

The advanced clinical decision support platforms market is segmented into type, model, setting, and region. By type, the market is bifurcated into therapeutic and diagnostic. The diagnostic segment is further bifurcated into hospitals and ambulatory care. Therapeutic segment is further subdivided into hospitals and ambulatory care. By model, the market is divided into knowledge based and non-knowledge based. By setting, the market is classified into hospital and ambulatory care.

Region-wise; the market is analyzed across North America (U.S., Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).  Some of the major companies that operate in the global advanced clinical decision support platforms market include Siemens Healthineers, Wolters Kluwer, Zynx Health, Oracle Corporation, IBM Watson Health, NextGen Healthcare Inc., Veradigm Inc., Meditech, Epic Systems Corporation, and Elsevier B.V.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the advanced clinical decision support platforms market analysis from 2021 to 2031 to identify the prevailing advanced clinical decision support platforms market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the advanced clinical decision support platforms market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global advanced clinical decision support platforms market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Relx Grou

Scope of Advanced Clinical Decision Support Platforms Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Growth in incidence of medication error

3.4.1.2. Increase in application of electronic health record system

3.4.1.3. Rise in geriatric population and increase in prevalence of chronic diseases

3.4.2. Restraints

3.4.2.1. Data security concerns related to cloud based CDSS

3.4.2.2. Increase in the incidence of data breach

3.4.3. Opportunities

3.4.3.1. Increase in number of adoptions of key strategies for development of market

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Therapeutic

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.2.4. Therapeutic Advanced Clinical Decision Support Platforms Market by Setting

4.2.4.1. Hospitals Market size and forecast, by region

4.2.4.2. Ambulatory care Market size and forecast, by region

4.3. Diagnostic

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.3.4. Diagnostic Advanced Clinical Decision Support Platforms Market by Setting

4.3.4.1. Hospitals Market size and forecast, by region

4.3.4.2. Ambulatory care Market size and forecast, by region

5.1. Overview

5.1.1. Market size and forecast

5.2. Knowledge based

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Non Knowledge based

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Ambulatory care

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key trends and opportunities

7.2.2. Market size and forecast, by Type

7.2.2.1. North America Therapeutic Advanced Clinical Decision Support Platforms Market by Setting

7.2.2.2. North America Diagnostic Advanced Clinical Decision Support Platforms Market by Setting

7.2.3. Market size and forecast, by Model

7.2.4. Market size and forecast, by Setting

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Key market trends, growth factors and opportunities

7.2.5.1.2. Market size and forecast, by Type

7.2.5.1.3. Market size and forecast, by Model

7.2.5.1.4. Market size and forecast, by Setting

7.2.5.2. Canada

7.2.5.2.1. Key market trends, growth factors and opportunities

7.2.5.2.2. Market size and forecast, by Type

7.2.5.2.3. Market size and forecast, by Model

7.2.5.2.4. Market size and forecast, by Setting

7.2.5.3. Mexico

7.2.5.3.1. Key market trends, growth factors and opportunities

7.2.5.3.2. Market size and forecast, by Type

7.2.5.3.3. Market size and forecast, by Model

7.2.5.3.4. Market size and forecast, by Setting

7.3. Europe

7.3.1. Key trends and opportunities

7.3.2. Market size and forecast, by Type

7.3.2.1. Europe Therapeutic Advanced Clinical Decision Support Platforms Market by Setting

7.3.2.2. Europe Diagnostic Advanced Clinical Decision Support Platforms Market by Setting

7.3.3. Market size and forecast, by Model

7.3.4. Market size and forecast, by Setting

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Key market trends, growth factors and opportunities

7.3.5.1.2. Market size and forecast, by Type

7.3.5.1.3. Market size and forecast, by Model

7.3.5.1.4. Market size and forecast, by Setting

7.3.5.2. France

7.3.5.2.1. Key market trends, growth factors and opportunities

7.3.5.2.2. Market size and forecast, by Type

7.3.5.2.3. Market size and forecast, by Model

7.3.5.2.4. Market size and forecast, by Setting

7.3.5.3. UK

7.3.5.3.1. Key market trends, growth factors and opportunities

7.3.5.3.2. Market size and forecast, by Type

7.3.5.3.3. Market size and forecast, by Model

7.3.5.3.4. Market size and forecast, by Setting

7.3.5.4. Italy

7.3.5.4.1. Key market trends, growth factors and opportunities

7.3.5.4.2. Market size and forecast, by Type

7.3.5.4.3. Market size and forecast, by Model

7.3.5.4.4. Market size and forecast, by Setting

7.3.5.5. Spain

7.3.5.5.1. Key market trends, growth factors and opportunities

7.3.5.5.2. Market size and forecast, by Type

7.3.5.5.3. Market size and forecast, by Model

7.3.5.5.4. Market size and forecast, by Setting

7.3.5.6. Rest of Europe

7.3.5.6.1. Key market trends, growth factors and opportunities

7.3.5.6.2. Market size and forecast, by Type

7.3.5.6.3. Market size and forecast, by Model

7.3.5.6.4. Market size and forecast, by Setting

7.4. Asia-Pacific

7.4.1. Key trends and opportunities

7.4.2. Market size and forecast, by Type

7.4.2.1. Asia-Pacific Therapeutic Advanced Clinical Decision Support Platforms Market by Setting

7.4.2.2. Asia-Pacific Diagnostic Advanced Clinical Decision Support Platforms Market by Setting

7.4.3. Market size and forecast, by Model

7.4.4. Market size and forecast, by Setting

7.4.5. Market size and forecast, by country

7.4.5.1. Japan

7.4.5.1.1. Key market trends, growth factors and opportunities

7.4.5.1.2. Market size and forecast, by Type

7.4.5.1.3. Market size and forecast, by Model

7.4.5.1.4. Market size and forecast, by Setting

7.4.5.2. China

7.4.5.2.1. Key market trends, growth factors and opportunities

7.4.5.2.2. Market size and forecast, by Type

7.4.5.2.3. Market size and forecast, by Model

7.4.5.2.4. Market size and forecast, by Setting

7.4.5.3. India

7.4.5.3.1. Key market trends, growth factors and opportunities

7.4.5.3.2. Market size and forecast, by Type

7.4.5.3.3. Market size and forecast, by Model

7.4.5.3.4. Market size and forecast, by Setting

7.4.5.4. Australia

7.4.5.4.1. Key market trends, growth factors and opportunities

7.4.5.4.2. Market size and forecast, by Type

7.4.5.4.3. Market size and forecast, by Model

7.4.5.4.4. Market size and forecast, by Setting

7.4.5.5. South Korea

7.4.5.5.1. Key market trends, growth factors and opportunities

7.4.5.5.2. Market size and forecast, by Type

7.4.5.5.3. Market size and forecast, by Model

7.4.5.5.4. Market size and forecast, by Setting

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Key market trends, growth factors and opportunities

7.4.5.6.2. Market size and forecast, by Type

7.4.5.6.3. Market size and forecast, by Model

7.4.5.6.4. Market size and forecast, by Setting

7.5. LAMEA

7.5.1. Key trends and opportunities

7.5.2. Market size and forecast, by Type

7.5.2.1. LAMEA Therapeutic Advanced Clinical Decision Support Platforms Market by Setting

7.5.2.2. LAMEA Diagnostic Advanced Clinical Decision Support Platforms Market by Setting

7.5.3. Market size and forecast, by Model

7.5.4. Market size and forecast, by Setting

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Key market trends, growth factors and opportunities

7.5.5.1.2. Market size and forecast, by Type

7.5.5.1.3. Market size and forecast, by Model

7.5.5.1.4. Market size and forecast, by Setting

7.5.5.2. Saudi Arabia

7.5.5.2.1. Key market trends, growth factors and opportunities

7.5.5.2.2. Market size and forecast, by Type

7.5.5.2.3. Market size and forecast, by Model

7.5.5.2.4. Market size and forecast, by Setting

7.5.5.3. South Africa

7.5.5.3.1. Key market trends, growth factors and opportunities

7.5.5.3.2. Market size and forecast, by Type

7.5.5.3.3. Market size and forecast, by Model

7.5.5.3.4. Market size and forecast, by Setting

7.5.5.4. Rest of LAMEA

7.5.5.4.1. Key market trends, growth factors and opportunities

7.5.5.4.2. Market size and forecast, by Type

7.5.5.4.3. Market size and forecast, by Model

7.5.5.4.4. Market size and forecast, by Setting

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2021

9.1. IBM Watson Health

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.1.6. Business performance

9.1.7. Key strategic moves and developments

9.2. Meditech

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.3. NextGen Healthcare Inc.

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.3.6. Business performance

9.4. Siemens Healthineers

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.4.6. Business performance

9.4.7. Key strategic moves and developments

9.5. Veradigm Inc.

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.5.6. Business performance

9.5.7. Key strategic moves and developments

9.6. Wolters Kluwer

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.6.6. Business performance

9.6.7. Key strategic moves and developments

9.7. Zynx health

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.8. Oracle Corporation

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.8.6. Business performance

9.8.7. Key strategic moves and developments

9.9. Epic Systems Corporation

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.9.6. Key strategic moves and developments

9.10. Relx Group

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfolio

9.10.6. Business performance

9.10.7. Key strategic moves and development

LIST OF TABLES

TABLE 01. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 02. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR THERAPEUTIC, BY REGION, 2021-2031 ($MILLION)

TABLE 03. GLOBAL THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 04. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 05. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)

TABLE 06. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR DIAGNOSTIC, BY REGION, 2021-2031 ($MILLION)

TABLE 07. GLOBAL DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 08. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 09. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)

TABLE 10. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 11. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR KNOWLEDGE BASED, BY REGION, 2021-2031 ($MILLION)

TABLE 12. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR NON KNOWLEDGE BASED, BY REGION, 2021-2031 ($MILLION)

TABLE 13. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 14. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 15. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)

TABLE 16. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 17. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 18. NORTH AMERICA THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 19. NORTH AMERICA DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 20. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 21. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 22. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 23. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 24. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 25. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 26. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 27. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 28. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 29. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 30. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 31. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 32. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 33. EUROPE THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 34. EUROPE DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 35. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 36. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 37. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 38. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 39. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 40. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 41. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 42. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 43. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 44. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 45. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 46. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 47. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 48. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 49. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 50. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 51. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 52. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 53. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 54. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 55. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 56. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 57. ASIA-PACIFIC THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 58. ASIA-PACIFIC DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 59. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 60. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 61. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 62. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 63. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 64. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 65. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 66. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 67. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 68. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 69. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 70. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 71. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 72. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 73. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 74. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 75. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 76. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 77. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 78. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 79. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 80. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 81. LAMEA THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 82. LAMEA DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 83. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 84. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 85. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 86. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 87. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 88. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 89. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 90. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 91. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 92. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 93. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 94. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 95. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 96. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)

TABLE 97. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)

TABLE 98. IBM WATSON HEALTH: KEY EXECUTIVES

TABLE 99. IBM WATSON HEALTH: COMPANY SNAPSHOT

TABLE 100. IBM WATSON HEALTH: PRODUCT SEGMENTS

TABLE 101. IBM WATSON HEALTH: PRODUCT PORTFOLIO

TABLE 102. IBM WATSON HEALTH: KEY STRATERGIES

TABLE 103. MEDITECH: KEY EXECUTIVES

TABLE 104. MEDITECH: COMPANY SNAPSHOT

TABLE 105. MEDITECH: SERVICE SEGMENTS

TABLE 106. MEDITECH: PRODUCT PORTFOLIO

TABLE 107. NEXTGEN HEALTHCARE INC.: KEY EXECUTIVES

TABLE 108. NEXTGEN HEALTHCARE INC.: COMPANY SNAPSHOT

TABLE 109. NEXTGEN HEALTHCARE INC.: PRODUCT SEGMENTS

TABLE 110. NEXTGEN HEALTHCARE INC.: PRODUCT PORTFOLIO

TABLE 111. SIEMENS HEALTHINEERS: KEY EXECUTIVES

TABLE 112. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT

TABLE 113. SIEMENS HEALTHINEERS: PRODUCT SEGMENTS

TABLE 114. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO

TABLE 115. SIEMENS HEALTHINEERS: KEY STRATERGIES

TABLE 116. VERADIGM INC.: KEY EXECUTIVES

TABLE 117. VERADIGM INC.: COMPANY SNAPSHOT

TABLE 118. VERADIGM INC.: PRODUCT SEGMENTS

TABLE 119. VERADIGM INC.: PRODUCT PORTFOLIO

TABLE 120. VERADIGM INC.: KEY STRATERGIES

TABLE 121. WOLTERS KLUWER: KEY EXECUTIVES

TABLE 122. WOLTERS KLUWER: COMPANY SNAPSHOT

TABLE 123. WOLTERS KLUWER: SERVICE SEGMENTS

TABLE 124. WOLTERS KLUWER: PRODUCT PORTFOLIO

TABLE 125. WOLTERS KLUWER: KEY STRATERGIES

TABLE 126. ZYNX HEALTH: KEY EXECUTIVES

TABLE 127. ZYNX HEALTH: COMPANY SNAPSHOT

TABLE 128. ZYNX HEALTH: PRODUCT SEGMENTS

TABLE 129. ZYNX HEALTH: PRODUCT PORTFOLIO

TABLE 130. ORACLE CORPORATION: KEY EXECUTIVES

TABLE 131. ORACLE CORPORATION: COMPANY SNAPSHOT

TABLE 132. ORACLE CORPORATION: PRODUCT SEGMENTS

TABLE 133. ORACLE CORPORATION: PRODUCT PORTFOLIO

TABLE 134. ORACLE CORPORATION: KEY STRATERGIES

TABLE 135. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES

TABLE 136. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT

TABLE 137. EPIC SYSTEMS CORPORATION: SERVICE SEGMENTS

TABLE 138. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO

TABLE 139. EPIC SYSTEMS CORPORATION: KEY STRATERGIES

TABLE 140. RELX GROUP: KEY EXECUTIVES

TABLE 141. RELX GROUP: COMPANY SNAPSHOT

TABLE 142. RELX GROUP: SERVICE SEGMENTS

TABLE 143. RELX GROUP: PRODUCT PORTFOLIO

TABLE 144. RELX GROUP: KEY STRATERGIES LIST OF FIGURES

FIGURE 01. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET (2022-2031)

FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 05. LOW BARGAINING POWER OF BUYERS

FIGURE 06. LOW THREAT OF SUBSTITUTES

FIGURE 07. LOW THREAT OF NEW ENTRANTS

FIGURE 08. LOW INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET

FIGURE 10. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR THERAPEUTIC, BY COUNTRY 2021-2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR DIAGNOSTIC, BY COUNTRY 2021-2031(%)

FIGURE 13. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR KNOWLEDGE BASED, BY COUNTRY 2021-2031(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR NON KNOWLEDGE BASED, BY COUNTRY 2021-2031(%)

FIGURE 16. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY COUNTRY 2021-2031(%)

FIGURE 19. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY REGION, 2021

FIGURE 20. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 21. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 22. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 23. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 24. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 25. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 26. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 27. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 28. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 29. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 30. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 31. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 32. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 33. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 34. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 35. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 36. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 37. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 38. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)

FIGURE 39. TOP WINNING STRATEGIES, BY YEAR

FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 43. COMPETITIVE DASHBOARD

FIGURE 44. COMPETITIVE HEATMAP: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET

FIGURE 45. TOP PLAYER POSITIONING, 2021

FIGURE 46. IBM WATSON HEALTH: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 47. IBM WATSON HEALTH: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 48. IBM WATSON HEALTH: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 49. NEXTGEN HEALTHCARE INC.: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 50. NEXTGEN HEALTHCARE INC.: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 51. SIEMENS HEALTHINEERS: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 52. SIEMENS HEALTHINEERS: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 53. SIEMENS HEALTHINEERS: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 54. VERADIGM INC.: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 55. VERADIGM INC.: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 56. VERADIGM INC.: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 57. WOLTERS KLUWER: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 58. WOLTERS KLUWER: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 59. ORACLE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 60. ORACLE CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022

FIGURE 61. ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 62. ORACLE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 63. RELX GROUP: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 64. RELX GROUP: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 65. RELX GROUP: REVENUE SHARE BY REGION, 2021 (%